Mayne Pharma | MYX - 销售收入

股票价格
2.28
每天变化
-0.01 -0.44%
每月一次
-6.94%
每年
-68.51%
Q1 预测
2.24


金融业
股票价格
AUD
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD -0.15
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 194.82M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 212.07M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


销售 更改 日
Ansell USD 1.03B 192.2M 2025-12
Avita Medical AUD 17.61M 805K 2025-12
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Healius AUD 688.1M 245.8M 2025-12
Integral Diagnostics AUD 238.44M 7.19M 2024-06
Medical Developments International AUD 21.57M 12.04M 2025-12
Nanosonics AUD 102.23M 2.8M 2025-12
Polynovo AUD 70.33M 35.75M 2025-12
Ramsay Health Care AUD 9.34B 82.2M 2025-12
ResMed USD 1.42B 87.23M 2025-12
Sigma Healthcare AUD 1.68B 188.65M 2024-12
Sonic Healthcare AUD 5.45B 470M 2025-12
Telix Pharmaceuticals AUD 413.44M 103.71M 2025-12